Latest News About Lung Cancer Treatment
Lung cancer claims life of BYU employee (Brigham Young NewsNet)
The ASB flag was lowered to half-staff Wednesday in honor of a BYU Carpenter Shop employee, who died Saturday after battling lung disease.
The ASB flag was lowered to half-staff Wednesday in honor of a BYU Carpenter Shop employee, who died Saturday after battling lung disease.
Lung cancer increases in non-smokers (Kathimerini)
Smokers aren?t the only ones who can contract lung cancer. New data show that the disease is spreading to non-smokers who inhale second-hand smoke or who live or work in environments filled with pollutants such as asbestos, arsenic, benzopyrene, chromium, nickel and pesticides.
Smokers aren?t the only ones who can contract lung cancer. New data show that the disease is spreading to non-smokers who inhale second-hand smoke or who live or work in environments filled with pollutants such as asbestos, arsenic, benzopyrene, chromium, nickel and pesticides.
Iron and calcium may up risk of lung cancer (Reuters via Yahoo! News)
Small amounts of iron and calcium in the diet or in the form of supplements may play an important role in the development of lung cancer, especially among smokers, a study suggests.
Small amounts of iron and calcium in the diet or in the form of supplements may play an important role in the development of lung cancer, especially among smokers, a study suggests.
M.D. Anderson debuts new lung cancer treatment (BizJournals)
ORLANDO -- When he was 12 years old, Thomas Vincent began stealing cigarettes from his father. "I smoked whichever brand of cigarettes I could get my hands on," he says.
ORLANDO -- When he was 12 years old, Thomas Vincent began stealing cigarettes from his father. "I smoked whichever brand of cigarettes I could get my hands on," he says.
Iron, calcium linked to lung cancer (Nutraingredients.com)
12/5/2005 - Iron and calcium are linked to a higher risk of lung cancer in new research from the Harvard School of Public Health.
12/5/2005 - Iron and calcium are linked to a higher risk of lung cancer in new research from the Harvard School of Public Health.
Race can affect decision about lung cancer treatment (EurekAlert!)
Race may play a role in whether a patient accepts surgical treatment for lung cancer. A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites, leading researchers to believe that blacks may be misinformed about the effects of lung cancer surgery.
Race may play a role in whether a patient accepts surgical treatment for lung cancer. A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites, leading researchers to believe that blacks may be misinformed about the effects of lung cancer surgery.
Vanderbilt-Ingram Cancer Center testing new lung cancer treatment (Nashville Business Journal)
Researchers at the Vanderbilt-Ingram Cancer Center are enrolling patients for a study involving a treatment of cancerous lesions in lungs.
Researchers at the Vanderbilt-Ingram Cancer Center are enrolling patients for a study involving a treatment of cancerous lesions in lungs.
Novelos Therapeutics Gets Green Light from FDA for Phase 3 Development in Lung Cancer (Business Wire via Yahoo! Finance)
NEWTON, Mass.----Dec. 5, 2005--Novelos Therapeutics, Inc. , a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Food and Drug Administration agreed that advancing NOV-002 into a single pivotal Phase 3 study in advanced non-small cell lung cancer , in combination with first-line chemotherapy, is warranted at this time.
NEWTON, Mass.----Dec. 5, 2005--Novelos Therapeutics, Inc. , a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Food and Drug Administration agreed that advancing NOV-002 into a single pivotal Phase 3 study in advanced non-small cell lung cancer , in combination with first-line chemotherapy, is warranted at this time.
Novelos gets FDA OK for lung cancer trial (Mass High Tech)
Novelos Therapeutics Inc., a Newton company focused on the development of therapeutics to treat cancer and hepatitis, has received approval from the Food and Drug Administration for trials of the company?s NOV-002 into a single pivotal Phase 3 study in advanced non-small cell lung cancer, in combination with first-line chemotherapy.
Novelos Therapeutics Inc., a Newton company focused on the development of therapeutics to treat cancer and hepatitis, has received approval from the Food and Drug Administration for trials of the company?s NOV-002 into a single pivotal Phase 3 study in advanced non-small cell lung cancer, in combination with first-line chemotherapy.
Long wait for Lothians lung cancer victims (The Scotsman: Health)
ONE in five people diagnosed with Scotland's biggest cancer killer in the Lothians is not being seen by a specialist within target times.
ONE in five people diagnosed with Scotland's biggest cancer killer in the Lothians is not being seen by a specialist within target times.